The movement of viral vectors, cell therapies and other antibody-based next-generation drug products toward commercialization is driving the need for new and different technologies and facilities. These facilities need to be more flexible and suited for multiproduct manufacturing. Large stainless steel tanks will remain part of the solution, but single-use systems for upstream and downstream operations are increasingly important.
Choose Your Location
To customize your experience, select an IPS region or country to view specific information based on your location.
- United States
- All Other Countries
You’ve chosen as your location.
Thank you for choosing a location. This will help us show the information that means to most to you. Continue to the homepage to view featured projects, and happenings specific to your location.